Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

[Prevalence of hypertension in overweight and obese Hungarian children and adolescents].

Jakab AE, Hidvégi EV, Illyés M, Cziráki A, Kalmár T, Maróti Z, Bereczki C.

Orv Hetil. 2020 Jan;161(4):151-160. doi: 10.1556/650.2020.31543. Hungarian.

PMID:
31955583
2.

Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.

Iung B, Delgado V, Rosenhek R, Price S, Prendergast B, Wendler O, De Bonis M, Tribouilloy C, Evangelista A, Bogachev-Prokophiev A, Apor A, Ince H, Laroche C, Popescu BA, Piérard L, Haude M, Hindricks G, Ruschitzka F, Windecker S, Bax JJ, Maggioni A, Vahanian A; EORP VHD II Investigators.

Circulation. 2019 Sep 12. doi: 10.1161/CIRCULATIONAHA.119.041080. [Epub ahead of print]

PMID:
31510787
3.

Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD.

Böcskei RM, Benczúr B, Losonczy G, Illyés M, Cziráki A, Müller V, Bohács A, Bikov A.

Lung. 2019 Apr;197(2):189-197. doi: 10.1007/s00408-019-00211-w. Epub 2019 Feb 28.

4.

Transcutaneous Carbon Dioxide Treatment Is Capable of Reducing Peripheral Vascular Resistance in Hypertensive Patients.

Németh B, Kiss I, Ajtay B, Péter I, Kreska Z, Cziráki A, Horváth IG, Ajtay Z.

In Vivo. 2018 Nov-Dec;32(6):1555-1559. doi: 10.21873/invivo.11414.

5.

Prevalence of Overweight and Obesity in Hungarian Children and Adolescents.

Jakab AE, Hidvégi EV, Illyés M, Cziráki A, Bereczki C.

Ann Nutr Metab. 2018;72(4):259-264. doi: 10.1159/000487929. Epub 2018 Mar 29.

PMID:
29597205
6.

[Asymmetric dimethylarginine: predictor of cardiovascular diseases?].

Németh B, Kustán P, Németh Á, Lenkey Z, Cziráki A, Kiss I, Sulyok E, Ajtay Z.

Orv Hetil. 2016 Mar 27;157(13):483-7. doi: 10.1556/650.2016.30396. Review. Hungarian.

PMID:
26996894
7.

Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial.

Kristensen SL, Preiss D, Jhund PS, Squire I, Cardoso JS, Merkely B, Martinez F, Starling RC, Desai AS, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, McMurray JJ, Packer M; PARADIGM-HF Investigators and Committees.

Circ Heart Fail. 2016 Jan;9(1). pii: e002560. doi: 10.1161/CIRCHEARTFAILURE.115.002560.

8.

Pericardial fluid of cardiac patients elicits arterial constriction: role of endothelin-1.

Nemeth Z, Cziraki A, Szabados S, Horvath I, Koller A.

Can J Physiol Pharmacol. 2015 Sep;93(9):779-85. doi: 10.1139/cjpp-2015-0030. Epub 2015 Apr 17.

PMID:
26322806
9.

Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac Hypertrophy.

Nemeth Z, Cziraki A, Szabados S, Biri B, Keki S, Koller A.

PLoS One. 2015 Aug 27;10(8):e0135498. doi: 10.1371/journal.pone.0135498. eCollection 2015.

10.

Tisztelt Szerkesztőség!

Benczúr B, Illyés M, Cziráki A, Böcskei R.

Orv Hetil. 2015 Jun 21;156(25):1026-8. doi: 10.1556/650.2015.25M. Hungarian. No abstract available.

PMID:
26170092
11.

The effect of physical exercise on arterial stiffness parameters in young sportsmen.

Rátgéber L, Lenkey Z, Németh Á, Hidvégi E, Husznai R, Verzár Z, Miklós I, Bódis J, Cziráki A.

Acta Cardiol. 2015 Feb;70(1):59-65.

PMID:
26137804
12.

Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry.

Fauchier L, Greenlaw N, Ferrari R, Ford I, Fox KM, Tardif JC, Tendera M, Steg PG; CLARIFY Investigators.

PLoS One. 2015 Apr 27;10(4):e0125164. doi: 10.1371/journal.pone.0125164. eCollection 2015.

13.

Influence of body height on aortic systolic pressure augmentation and wave reflection in childhood.

Hidvégi EV, Illyés M, Molnár FT, Cziráki A.

J Hum Hypertens. 2015 Aug;29(8):495-501. doi: 10.1038/jhh.2014.118. Epub 2014 Dec 11.

PMID:
25500901
14.

Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.

Packer M, McMurray JJ, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile M, Andersen K, Arango JL, Arnold JM, Bělohlávek J, Böhm M, Boytsov S, Burgess LJ, Cabrera W, Calvo C, Chen CH, Dukat A, Duarte YC, Erglis A, Fu M, Gomez E, Gonzàlez-Medina A, Hagège AA, Huang J, Katova T, Kiatchoosakun S, Kim KS, Kozan Ö, Llamas EB, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires FJ, Refsgaard J, Rosenthal A, Senni M, Sibulo AS Jr, Silva-Cardoso J, Squire IB, Starling RC, Teerlink JR, Vanhaecke J, Vinereanu D, Wong RC; PARADIGM-HF Investigators and Coordinators.

Circulation. 2015 Jan 6;131(1):54-61. doi: 10.1161/CIRCULATIONAHA.114.013748. Epub 2014 Nov 17.

PMID:
25403646
15.

Short-term response of metabolic hormones to coronary artery bypass surgery.

Németh Á, Cziráki A, Sulyok E, Horváth IG, Alotti N, Rauh M, Rascher W, Szabados S.

Adv Med Sci. 2014 Sep;59(2):213-20. doi: 10.1016/j.advms.2014.04.002. Epub 2014 Jun 9.

PMID:
25323760
16.

Ivabradine in stable coronary artery disease without clinical heart failure.

Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R; SIGNIFY Investigators.

N Engl J Med. 2014 Sep 18;371(12):1091-9. doi: 10.1056/NEJMoa1406430. Epub 2014 Aug 31.

17.

Angiotensin-neprilysin inhibition versus enalapril in heart failure.

McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Investigators and Committees.

N Engl J Med. 2014 Sep 11;371(11):993-1004. doi: 10.1056/NEJMoa1409077. Epub 2014 Aug 30.

18.

Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients.

Kalra PR, García-Moll X, Zamorano J, Kalra PA, Fox KM, Ford I, Ferrari R, Tardif JC, Tendera M, Greenlaw N, Steg PG; CLARIFY Investigators.

PLoS One. 2014 Jul 22;9(7):e102335. doi: 10.1371/journal.pone.0102335. eCollection 2014.

19.

Comparison of arterial stiffness parameters in patients with coronary artery disease and diabetes mellitus using Arteriograph.

Lenkey Z, Illyés M, Böcskei R, Husznai R, Sárszegi Z, Meiszterics Z, Molnár FT, Hild G, Szabados S, Cziráki A, Gaszner B.

Physiol Res. 2014;63(4):429-37. Epub 2014 Apr 3.

20.

Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).

McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau J, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Committees and Investigators.

Eur J Heart Fail. 2013 Sep;15(9):1062-73. doi: 10.1093/eurjhf/hft052. Epub 2013 Apr 5.

Supplemental Content

Loading ...
Support Center